[21VIANET GROUP, INC. INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Page Contents Condensed Consolidated Balance Sheet as of December 31, 2019 and Unaudited Interim Condensed Consolidated Balance Sheet as of June 30, 2020 F-2 F-5 Unaudited Interim Condensed Consolidated Statements of Operati]
[21VIANET GROUP, INC. INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Page Contents Condensed Consolidated Balance Sheet as of December 31, 2019 and Unaudited Interim Condensed Consolidated Balance Sheet as of June 30, 2020 F-2 F-5 Unaudited Interim Condensed Consolidated Statements of Operati]
[] [August 24, 2020 To the Board of Directors Future FinTech Group Inc. 2103 Tower A, SK Plaza, A6 JianGuoMenWai Avenue, Chaoyang District Beijing, P.R. China 100022 Re: Primary Registration Statement on Form S-3 Ladies and Gentlemen: Company Registration Statement Commission Act Common Stock Preferr]
[Daqo New Energy Announces A Long-Term High-Purity Polysilicon Supply Agreement with Wuxi Shangji Automation Shihezi, China -- August 24, 2020 -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy", the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV indu]
[] [August 24, 2020 To the Board of Directors Future FinTech Group Inc. 2103 Tower A, SK Plaza, A6 JianGuoMenWai Avenue, Chaoyang District Beijing, P.R. China 100022 Re: Primary Registration Statement on Form S-3 Ladies and Gentlemen: Company Registration Statement Commission Act Common Stock Preferr]
[Daqo New Energy Announces A Long-Term High-Purity Polysilicon Supply Agreement with Wuxi Shangji Automation Shihezi, China -- August 24, 2020 -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy", the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV indu]
[BOQI International Medical Announces Nasdaq Notification of Deficiency In accordance with the Nasdaq Listing Rules, The Company was provided 60 calendar days to submit its plan to regain compliance with the Nasdaq Listing Rules. If Nasdaq accepts the Company’s plan, then Nasdaq may grant the Company]
[Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021 1Q21 Added 17,233 New Subscribers Revenues Up 2.8% YoY to RMB280.9 Million ($39.8 Million) Gross Profit Up 4.3% YoY to RMB237.5 million ($33.6 million) Operating Income Up 18.8% YoY to RMB133.5 Million ($18.]
[BOQI International Medical Announces Nasdaq Notification of Deficiency In accordance with the Nasdaq Listing Rules, The Company was provided 60 calendar days to submit its plan to regain compliance with the Nasdaq Listing Rules. If Nasdaq accepts the Company’s plan, then Nasdaq may grant the Company]
[Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021 1Q21 Added 17,233 New Subscribers Revenues Up 2.8% YoY to RMB280.9 Million ($39.8 Million) Gross Profit Up 4.3% YoY to RMB237.5 million ($33.6 million) Operating Income Up 18.8% YoY to RMB133.5 Million ($18.]
